MSD Animal Health has launched a dairy calf heath checklist app, designed to help the veterinary professionals and farmers draw up action plans to improve calf health together.

The app, which works on tablets and smartphones, allows vets to e-mail audit results directly to clients following an interactive calf health assessment at the farm.

MSD Animal Health’s youngstock marketing manager Robert Simpson said: “Our new app allows both parties to explore, record and score calf health performance across five core areas to identify the strengths and weaknesses of any rearing unit’s environment and processes. 

“Working through a series of 10 questions within each core area – designed to tease out where a rearing unit is in terms of accepted best management practice – allows vet and farmer to quickly pinpoint any areas needing attention.

"What’s more, repeating the checklist every six or 12 months is a great way to keep things on track, allowing both parties to monitor progress against agreed targets”.

For more information about the app, contact your MSD account manager.

The British Medical Ultrasound Society is inviting vets to come to its Annual Scientific Medical Ultrasound Conference in Harrogate on the 12th December, where it will be running a veterinary stream aimed at veterinary GPs with an interest in ultrasound.

Lecture topics will include interesting cases, the importance of systematic abdominal technique, the challenge of becoming ultrasound competent within a primary referral setting, basic anaesthetic nerve blocks, using ultrasound for appropriate medical management, how CASE can support competency based veterinary ultrasound training and more.

The session will end with a debate on whether it is time for a formal / stand alone Veterinary Ultrasound training programme and who should accredit such courses.

Speakers include Natasha Dickinson from Cave Veterinary Specialists, Niamh Casey from Village Vets, Miguel Martinez from Northwest Veterinary Specialists, Will Humphreys from the University of Liverpool and Nuala Summerfield from Virtual Veterinary Specialists.

The day costs £75 (sounds like a steal, if you ask me), and you can register here: https://www.bmus.org/meeting-booking/ultrasound-2019/

Animalcare's new Cephacare flavour antibiotic has received a response of 'good' or 'very good' in 80% of cases in a recent field study of superficial pyoderma in dogs. When asked to rate the effectiveness of the cephalexin-based antibiotic, more than half of the cases were awarded the highest response level of 'very good'.

Animalcare asked vets from across the country to participate in the study in order to confirm the company's own opinion. Each vet recorded five cases of superficial pyoderma in dogs and scored the effectiveness of treating the condition with Cephacare flavour. The first vets to complete their assessment forms received a free copy of the BSAVA Manual of Small Animal Dermatology worth £85.

The antibiotic proved effective across 19 different breeds, with animal weights ranging from 7kg to 70kg. Varying degrees of condition severity from mild through to severe were recorded with the average treatment length being 14-17 days. A number of 'severe' cases were treated with positive results. Severe was defined as long standing or recurrent areas of papules, crusting papules, epidermal collarettes and intact pustules.

Tony Liepman, Animalcare Market Manager, said: "A study like this confirms the product's effectiveness and, importantly, the acceptance of Cephacare flavour in real-world cases."

Unite and the British Veterinary Union (BVU) have written to the government asking for the Professional Standards Authority (PSA), which  regulates such governing bodies as the General Medical Council,  General Dental Council, and Nursing and Midwifery Council (NMC), to have 'scrutiny' of the RCVS.

In a letter to junior minister at the Department for Environment, Food and Rural Affairs, George Eustice, the BVU chair  Dr Shams Mir cited the case of Munhuwepasi Chikosi struck off the register of veterinary surgeons by the RCVS in June 2013.

Dr Mir said that this case was "widely seen by the veterinary profession as blatant miscarriage of justice and many expressions of 'outrage' were published in the veterinary press and online.

"One popular online veterinary forum recorded over a thousand posts criticising and challenging various aspects of the decision."

The current statutory duties of the RCVS, established by Royal Charter in 1844, are determined by the Veterinary Surgeons Act (VSA) of 1966, which Unite says is now 'outdated.

Dr Mir said: "BVU petitions the government to extend the remit of the PSA to incorporate the RCVS to ensure appropriate overview and scrutiny.

"The RCVS proposed new Royal Charter could be exploited by the RCVS to give itself proxy powers to introduce incontestable new regulatory measures."

Unite has asked for an urgent meeting with Mr. Eustice. 

Unite professional officer Jane Beach said: "Our initiative is designed to safeguard the interests of both the public, and practicing vets and veterinary nurses in the UK.

"Basically, the way that the RCVS is presently constituted means that it is both judge and jury in disciplinary matters. It sets the rules and hands down the judgements - and we believe that an extra layer of scrutiny needs to be introduced which we would like to be the PSA."

AMufacture has launched The Ear Protector, designed to make face masks more comfortable for people working in public-facing businesses. 

The Ear Protector sits on the back of the head and hooks onto face mask strings, pulling them backwards and away from the ears, thereby relieving pressure and stopping chafing. 

The product was designed by AMufacture's Chief Operating Officer, William Howden, a former Olympic sailor who competed in the 2008 Summer Olympics in Beijing. He said: "Early in the pandemic, it became apparent to us that there was a serious need to address an unresolved problem with face masks – people were really beginning to suffer and were getting distracted from their work."

The Ear Protector is sterilisable in a dishwasher. It is also recyclable when it reaches the end of its life.

The Ear Protectors cost fifty pence each, for orders of two hundred. Contact the company direct for lower volume pricing.

For more information, visit: http://www.theearprotector.com 

Researchers at the Royal Veterinary College report that they've made a significant breakthrough in the search for a durable treatment for Duchenne muscular dystrophy (DMD).

Working in collaboration with researchers at University of Texas, Southwestern (UTSW) Medical Center, the team has succeeded in using gene editing techniques on dogs to restore the expression of the dystrophin protein that is absent in DMD patients’ muscles to levels that could be life changing.

DMD is the most common, fatal, genetic disease that affects children. The same disorder also occurs in many dog breeds. It is caused by mutations in the gene that encodes dystrophin, a crucial protein that helps protect muscle fibres and the heart when they contract. Patients with the disease produce effectively no dystrophin protein, so their muscles and heart become damaged during contraction, leading to inability to walk, skeletal deformities, breathing problems and heart failure. Patients with DMD have a life expectancy that does not go far beyond their twenties.

Researchers say that this preliminary research, published in Science, demonstrates an approach that could lead to an effective, in principle one-time treatment for DMD for the most common genetic mutations affecting human patients. Through a single intravenous injection, researchers have been able to modify the dystrophin gene in many muscles of the body, including the heart, with the result that some muscles now had almost the normal amounts of dystrophin protein.

The team, led by Eric Olson, Ph.D., professor and chair of the Department of Molecular Biology at UTSW Medical Center and founder and chief science advisor of Exonics Therapeutics, and Richard Piercy, Ph.D., MRCVS, Professor of Comparative Neuromuscular Disease at the RVC, identified a naturally-occurring mutation in the dystrophin gene in a dog brought to the RVC’s Small Animal Referral Hospital.

Working now with relatives of this first dog, the combined group has used a technique called ‘SingleCut CRISPR gene editing’, where the researchers target a specific region of the subject’s own DNA. Harmless viruses encoding the gene-editing protein CRISPR/Cas9 were used to express the enzyme in muscle to cut the dogs’ own DNA at a precise location in the dystrophin gene through use of a molecular guide. The body’s own processes then repair the cut, which results in removing the negative effects of the existing mutation.

The researchers have demonstrated that dogs treated in this way had restored ability to produce large amounts of the dystrophin protein in their muscles and heart, and in the dog with the highest dose, cardiac muscles were found to have restored dystrophin protein to up to 92% of normal amounts after the single treatment.

The team believes this is the first time that this form of gene editing therapy has been conducted after birth in an animal larger than a rodent. With further longer-term research, efficacy and safety testing, it is hoped that this breakthrough will have human application. This treatment may be a significant step toward developing a gene editing therapy to repair genetic mutations for DMD, as well as a range of diseases caused by genetic mutations.   

Richard Piercy, Professor of Comparative Neuromuscular Disease at the RVC, said: "Researchers have been looking for an effective and durable treatment for Duchenne muscular dystrophy for many years. This SingleCut gene editing approach, pioneered by Dr. Eric Olson’s group, has the potential to be a one-time treatment that could restore dystrophin protein. It is hugely exciting that through a single intravenous injection we’ve been able successfully to modify the dogs’ own DNA so they start generating dystrophin protein again. There is more work to be done, but with this exciting breakthrough, we feel we are a significant step closer to finding an effective treatment.

"A great many genetic diseases affect humans, dogs and other species - many, like DMD - with tragic consequences and this form of gene editing treatment might well be applicable in many of them. We’re hopeful that we’re paving the way for future research into treating some of the most serious genetic conditions that affect us today."

Irish small animal practitioner Stuart Fitzgerald MVB MANZCVS has launched the MobiVet Veterinary Formulary app for Android devices.

Available for download now, the MobiVet Veterinary Formulary App is designed to make drug calculations and prescribing faster, easier and safer. It contains dose rate and interval data for over 250 drugs commonly used in small animal practice.

Searchable by drug name or trade names, with species-specific dosing information, the app calculates doses based on the patient type, weight, or body surface area as appropriate. MobiVet also provides a checklist of known relevant drug interactions for each medication, to prevent prescribing errors.

Stuart says an iOS version is in production.

To download the Android version, visit: https://play.google.com/store/apps/details?id=com.project.user.drug_formulary&hl=en

The RCVS has published a recording of its recent webinar about its new ‘under care’ guidance.

During the webinar, which took place earlier this month, senior officers and staff from the College explained the new guidance, what it will mean for the profession, and answered questions submitted by delegates.

The webinar was chaired by RCVS President Dr Melissa Donald MRCVS with a panel comprising Standards Committee Chair Linda Belton MRCVS, RCVS Registrar Eleanor Ferguson, and RCVS Head of Standards Gemma Kingswell.

The webinar included an overview of the main changes, the considerations to take into account when prescribing POM-Vs remotely, the circumstances under which POM-Vs cannot be prescribed remotely, the prescription of antibiotics, antifungals, antiparasitics and antivirals, and how the guidance will be enforced.

Eleanor Ferguson, RCVS Registrar, said: “We have also now published a range of practice-based scenarios to help explain how the new guidance should be followed in various circumstances, and in relation to different species.

"These scenarios cover a variety of different situations, including how the guidance applies to two or more practices with mutual clients, consultancy services and the prescription of long-term controlled drugs.”

A second webinar will be held on Monday 17th July, with priority for those who wanted to attend the June webinar but were not able to do because it was over-subscribed. 

www.rcvs.org.uk/undercare

Kruuse has launched two products for the treatment of digital dermatitis in cattle: the Bovivet hoof bandage and Kruuse Hoof Gel.  

According to the company, an estimated that 70% of dairy herds suffer with digital dermatitis (DD), and it is a growing problem. If not treated, it can persist for months, causing pain and lameness to infected cows. As well as worrying animal welfare concerns, numerous studies have shown that the disease can have a direct impact on milk production and reproduction with financial implications for the dairy farmer.

Traditionally, treatment has involved thoroughly washing the infected hoof, applying an antibiotic/drying agent such as salicylic acid powder and then applying a dressing that must typically remain in place for three days. This method comes with its own problems, including the difficulty dosing salicyclic acid powder correctly, the risk to the user's health when mixing, and the difficulty ensuring that the dressing is correctly applied at the right pressure and that it stays in place.

To help overcome these problems, Kruuse has introduced two products. The first is the ready-to-apply Bovivet complete Hoof Bandage. It is made from a water-repelling material that keeps out unwanted liquids. Its shape and elasticity are designed to keep the bandage in place. Inside the bandage is a treatment pad that makes for easy dosing. The outer stocking design allows for checking on the progress of treatment and for re-application if necessary. The bandage is available in two sizes, large which fits most cattle breeds, and small for calves and small breeds.

The second product, to be used in conjunction with the Bovivet Hoof Bandage, is Kruuse Hoof Gel 38%, containing 38% salicyclic acid. Kruuse says that dosing with this gel product is easier and more accurate than with the powder, making it more economical per treatment. It also reduces potential health risks to the user from inhalation of the powder when mixing.

Kruuse has produced the following instructional video to demonstrate the new products' ease of use and versatility:

Pets'n'Vets, a Glasgow-based partnership, has revealed plans to open what it describes as the city's first veterinary 'super practice'.

Located at a 7500 sq ft customised facility in the Auldhouse Retail Park in Pollokshaws, The Roundhouse Veterinary Hospital will provide comprehensive pet care seven days a week, caring for animals around the clock and providing late night consultations when required. Pets'n'Vets says it believes it will deliver a step change to the standard of veterinary care available in the city.

Pets'n'Vets partner Oliver Jackson said: "Having provided excellent veterinary care to the Southside's pets for over 40 years we feel that this will create a cutting-edge facility in which to do so for the next 40 years.

"Our plans for this ambitious new facility have been modelled on the American concept of a vet 'super-practice', designed to deliver the whole suite of pet care services, from nail clipping to vaccinations to some of the most complex surgical veterinary procedures - and will provide these services locally, at sensible cost and to the highest clinical standards with one of the best qualified, first opinion veterinary surgeons in the West of Scotland and one of the best medical experts too.

"This is a really exciting initiative that will bring a real first to Glasgow. It will enable us to care for animals 24 hours a day as there will be nursing staff living on-site so that animals can receive continuous treatment through the night. The location of the facility means that pet owners and, more importantly, sick animals, will not have to travel too far and, given the size and scope of the facility, we expect to be able to reduce significantly the waiting list before veterinary procedures can be scheduled.

"The whole idea behind The Roundhouse Veterinary Hospital is that we will be in a position to provide continuous lifelong veterinary care regardless of the problems that life brings - our vets and nurses often first meet our friends and their pets as a puppies, kittens and kits and we get to know pet and owner exceptionally well over the years - in the event that that pet requires a complex surgical procedure or in-patient medical care, we want to be able to offer that too, rather than the pet and owner being referred to an unfamiliar veterinary hospital.

"A particularly exciting aspect of the development is that some of the services will be led by our qualified veterinary nurses in conjunction with the surgeons. To facilitate this, the practice will in addition to the vet consulting rooms, house two specialist nurse consulting rooms."

The Roundhouse Veterinary Hospital will feature a cat examination room which, unusually, will not feature a consult table. Instead, this new facility will feature steps and an artificial tree that will enable the nurse or vet to better assess its movements.

Partner Oliver Jackson said: "This is an ultra-modern arrangement which is aimed at allowing us to examine cats in a more natural way - we hope that this will assist us to diagnose many more cases of feline arthritis, a disease that a recent study accepted was often missed by the traditional, consulting table means of examining cats."

Similarly, the dog room will not feature a consult table but will have facilities for physiotherapy or play - and there will be a special garden enclosure for exercising any dogs requiring to stay at the facility for any length of time.

The 'super practice' will feature separate cat and dog waiting and consultation rooms as well as separate in-patient wards to reduce stress. In the clinical wing, the facility boasts two sterile theatres, specified to the highest clinical standards, with a separate scrub area, a designated dental theatre, large patient preparation area as well as state-of the art diagnostic suites.

Pets'n'Vets says the hospital design has been carefully considered to encourage the best possible clinical care. For example vets' stations overlook the intensive care unit and the preparation area remains open plan, taking advantage of natural light provided by a large overhead atrium, whilst specialist air extraction systems ensures sterility by separating the area into clinical zones.

In addition to the dog and cat accommodation the hospital will also have an isolation ward which will be separate for any animals with potentially contagious diseases and a ward dedicated to less usual pets with facilities for everything from rabbits and guinea pigs to albino hedgehogs as well as vivaria for looking after reptiles.

The Roundhouse Veterinary Hospital will also feature a private area for pet owners needing to spend a little more time, perhaps on those sad occasions when a pet has to be put to sleep, as well as a dedicated and more relaxed room where owners will be able to discuss the health of their pet with the vet.

Oliver said: "We want The Roundhouse to be a place for learning and meeting, so there will be a coffee station for owners and a homely, relaxed and welcoming feeling. We're also planning to host school trips and the facility will feature a little veterinary practice where kids can play, with stethoscopes and little white coats for them to wear.

"As a practice, Pets'n'Vets has always been very involved in training and this new facility will enable us to do that on an unprecedented scale. Our ambition is that The Roundhouse will become a drop-in centre for people to come with their animals to learn and to play as well as to receive medical treatment."

The Roundhouse Veterinary Hospital will create six additional full-time jobs when it opens this summer. Pets'n'Vets says that many of the treatments currently delivered by its nearby surgery on Pollokshaws Road will transfer to the new facility, enabling it to create Glasgow's first dedicated vaccine clinic at the old surgery.

MSD Animal Health - maker of Vidalta and Leventa - has announced the launch of Pet Thyroid Month, a campaign to help pet owners recognise the signs of thyroid diseases in cats and dogs and encourage them to seek advice from their veterinary practice.

Running in July, the campaign aims to raise awareness of hyperthyroidism in cats and hypothyroidism in dogs, educate pet owners to spot the symptoms and thereby encourage early diagnosis.

MSD Animal Health says it hopes the campaign will increase the number of pets being taken to their veterinary practice for diagnosis, and increase both return visits and treatment compliance.

Practices supporting Pet Thyroid Month will be supplied with resources to help them educate pet owners about the two conditions.

Caroline Darouj, product manager at MSD Animal Health, said: "Although hyperthyroidism in cats and hypothyroidism in dogs are well known conditions and diagnosis is generally straightforward, a large number of vets in Europe state that both disorders are under-diagnosed, due to the fact that pet owners don’t recognise the signs.

"We wanted to launch our Thyroid Month campaign to encourage pet owners to spot the early symptoms of thyroid issues in their pets and seek advice from their veterinary practices.

"Our aim is also to benefit and educate vets and vet nurses with regard to the use of Leventa and Vidalta in treating these manageable conditions in both dogs and cats."

To find out more about Pet Thyroid Month, visit www.vidalta.co.uk

Miele Professional has released the results of a survey¹ looking at how practices handle their laundry, finding that two thirds do not comply with WRAS Category 5 Regulations.

The research found that 93% of practices have a washing machine on site, but two thirds of those use a domestic machine rather than a commercial one. 69% of staff also take their uniform home to wash in a domestic machine.

Only commercial machines conform to the WRAS regulations, with thermal disinfection capabilities to minimise the risk of cross infection. 

The survey also provided an argument for using a robust commercial machine able to cope with high levels of usage and the variety of materials needing to be cleaned: 83% of practices said they use their machines more than once a day and listed bedding, drapes and gowns as the most common materials that need to be cleaned regularly. 

Les Marshall, Sales & Marketing Director at Miele Professional, said: "Our research shows that veterinary staff realise the importance of hygiene when cleaning their laundry. At Miele Professional we understand that preventing infection is key. When caring for animals who need medical care, reliable and effective equipment that can wash items ranging from bedding to gowns to reusable bandages is essential.

"As a leading supplier to the care and hospital sectors, all our machines are tested and approved to Water Regulatory Advisory Scheme (WRAS) category 5 for mains connection in any high-risk establishment."

The company says that in addition to meeting WRAS category 5 requirements, it's machines:

• have thermal disinfection capabilities, which kill 99.99% of all pathogenic germs and are suitable for killing both vegetative bacteria (including mycobacteria and fungi) and deactivating viruses.
• use commercial filters to capture any animal hair during the washing process, thereby stopping it get stuck in the drum or blocking drain pipes.
• are available with different drum sizes so they can handle the differing laundry requirements of a small animal practice to an equine practice which may require larger and denser items such as horse rugs to be cleaned.  

Miele Professional is exhibiting at the London Vet Show and will be holding a seminar on 'Controlling the risk of infection with a commercial laundry system' in the Business Theatre on 18 November, 12-12.50pm.

The seminar will explore the benefits of using a commercial laundry over a domestic machine, best practice around thermal disinfection and why it’s vital for veterinary practices to meet WRAS category 5 requirements.

For more information visit www.miele.co.uk.

Reference

• 95 respondents were surveyed online in June 2016

The British Veterinary Association (BVA) is pushing for a reform of the training and revalidation system for Official Veterinarians after conducting a survey of veterinary surgeons which found considerable levels of frustration with the existing system. 

1,300 veterinary surgeons responded to the BVA survey, which was carried out in July. They were asked what Official Controls Qualification (OCQ) they hold or have held in the past, and give reasons for dropping a previously held qualification or choosing not to revalidate. 

According to the BVA, many respondents criticised the current training and revalidation process, which is administered by Improve International on behalf of the Animal and Plant Health Agency (APHA). 

Factors including time, the cumulative cost of renewing each module at regular intervals, a lack of relevance and duplication of learning across different modules were all cited as reasons for choosing to drop qualifications.  

25% of vets who currently hold the Essential Skills OCQ say they are planning not to renew the qualification, with 67% saying it is because of the expiry of grandfather rights and 66% saying it is because they find the requirements too onerous.

18% of those who currently hold the Tuberculin Testing OCQ are not planning on renewing, either because they are finding the revalidation requirements too onerous (58%), too expensive (42%) or because the work is not sufficiently rewarding (42%).

35% of those who hold the Statutory Surveillance OCQ are not planning on renewing, primarily because of overly onerous revalidation requirements. 

The largest drop off is predicted amongst holders of the Exports OCQ, 38.4% of whom said they plan not to revalidate. 

Amongst the species bolt-ons, 45.5% of the holders of the Small Animal Exports OCQ, 51% of the Ungulate Exports OCQ, 66% of the Equine Exports OCQ, 72.5% of the Avian Exports OCQ, 47% of the Product Exports OCQ, 68% of the Germinal Products Exports OCQ and 32% of the Companion Animals OCQ said they plan not to renew, either because of the expiry of grandfather rights, or the expense or, in the case of Ungulate Exports, because revalidation is too onerous. 

In the current system equine exports are included in the ungulate export OCQ, which the BVA says was a concern for those vets who only work with farm animals. APHA and Improve International have helpfully introduced an equine-only OCQ for exports that better meets the needs of equine-only vets. 

BVA reports that it has had a positive meeting with APHA to discuss the survey results and explore practical solutions to iron out issues with the current system and make it easier to use. As a next step, BVA has agreed to review the modules and make recommendations for improving the structure of training and the revalidation process.

BVA President John Fishwick said: "The unprecedented response rate to this survey really hits home the strength of feeling on this issue. There is an urgent need to review and improve the revalidation process to safeguard against capacity and capability issues in this critical section of the workforce.

"It’s really positive that APHA recognises that there are issues with the current system and is keen to work with us to make it more proportionate and fit for purpose while continuing to maintain high standards.  It’s more important than ever to retain skilled professionals so that the workforce is at full strength to respond robustly to disease outbreaks and meet demand for export certification after Brexit."

Andrew Soldan, APHA Veterinary Director said: "The integrity of our official controls and export certification is vitally important. The Official Controls Qualifications are a key part of this as they provide standardised OV training as well as assurance of high standards.  I’m grateful to BVA for their assistance as we look to make further improvements to the system in the future."